Skip to main content
. 2022 Jan 6;17:3. doi: 10.1186/s13722-021-00285-z

Table 3.

Prevalence of marijuana use during pregnancy by MOUD and other substance exposures stratified by study group (N = 251)

Co-exposures OUD (n = 125) OUD + alcohol (n = 57) Alcohol (n = 69)
Marijuana use
(n = 54)
No Marijuana use (n = 71) Marijuana use
(n = 30)
No Marijuana use (n = 27) Marijuana use (n = 32) No marijuana use (n = 37)
n (%) n (%) n (%) n (%) n (%) n (%)
Type of MOUD
 Methadone 18 (37.5) 30 (62.5) 9 (42.9) 12 (57.1)
 Buprenorphine 33 (45.8) 39 (54.2) 21 (58.3) 15 (41.7)
 Methadone and buprenorphine 3 (60.0) 2 (40.0) 0 (0.0) 0 (0.0)
Other opioidsa
 Heroin 25 (49.0) 26 (51.0) 14 (56.0) 11 (44.0)
 Opioid analgesicsb 16 (53.3) 14 (46.7) 11 (52.4) 10 (47.6) 5 (55.6) 4 (44.4)
 Opiates detected by UDS only 1 (50.0) 1 (50.0) 0 (0.0) 2 (100.0)
Polysubstance usec 25 (55.6) 20 (44.4) 17 (58.6) 12 (41.4) 10 (58.8) 7 (41.2)
Tobacco use 48 (47.1) 54 (52.9) 27 (54.0) 23 (46.0) 14 (56.0) 11 (44.0)
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Average ounces of alcohol per day, LMP to Visit 1d 0.0 (0.0) 0 (0.0) 1.0 (1.6) 0.7 (1.1) 1.3 (2.2) 0.6 (1.5)
AUDIT score1 1.1 (1.7) 0.6 (1.0) 11.8 (8.4) 15.6 (10.9) 14.2 (8.1) 10.3 (9.0)

OUD opioid use disorder, GED General Educational Development, MOUD medication for opioid use disorder, UDS urine drug screen, LMP last menstrual period

aCategories are not mutually exclusive

bOpioid analgesic use in the Alcohol group was directed by a physician and did not constitute misuse

cPolysubstance use defined as using at least one other substance including: stimulants, benzodiazepines, sedatives, prescription medications (Soma/Carisoprodol), or hallucinogens

dAverage absolute ounces of alcohol per day across two 30-day timeline follow-back (TLFB) calendars

1p < 0.01 (Wald test from logistic regression model for the interaction between the AUDIT score and group classification)